Editorial: Mitochondrial and lysosomal dysfunction in neurodegenerative diseases: Molecular mechanisms and therapeutic strategies.
作者信息
Xiang Chen, Yousheng Xiao, Xiaolei Zhu, Wenjie Yang, Jiali Pu, Zhong Pei
机构信息
Department of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
出版信息
Front Aging Neurosci. 2022 Oct 4;14:1029440. doi: 10.3389/fnagi.2022.1029440. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Mitochondrial and lysosomal dysfunction in neurodegenerative diseases: Molecular mechanisms and therapeutic strategies.
Front Aging Neurosci. 2022 Oct 4;14:1029440. doi: 10.3389/fnagi.2022.1029440. eCollection 2022.
2
Secondary Mitochondrial Dysfunction as a Cause of Neurodegenerative Dysfunction in Lysosomal Storage Diseases and an Overview of Potential Therapies.
Int J Mol Sci. 2022 Sep 12;23(18):10573. doi: 10.3390/ijms231810573.
3
Mitochondrial Dysfunction and Neurodegeneration in Lysosomal Storage Disorders.
Trends Mol Med. 2017 Feb;23(2):116-134. doi: 10.1016/j.molmed.2016.12.003. Epub 2017 Jan 19.
4
Endo-lysosomal dysfunction: a converging mechanism in neurodegenerative diseases.
Curr Opin Neurobiol. 2018 Feb;48:52-58. doi: 10.1016/j.conb.2017.09.005. Epub 2017 Oct 10.
5
Lysosomal dysfunction impairs mitochondrial quality control and is associated with neurodegeneration in encephaloneuronopathy.
Brain Commun. 2021 Sep 16;3(4):fcab215. doi: 10.1093/braincomms/fcab215. eCollection 2021.
6
Mitochondrial biogenesis: pharmacological approaches.
Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118.
7
Mechanisms of Mitochondrial Dysfunction in Lysosomal Storage Disorders: A Review.
J Clin Med. 2020 Aug 11;9(8):2596. doi: 10.3390/jcm9082596.
8
The emerging roles of vacuolar-type ATPase-dependent Lysosomal acidification in neurodegenerative diseases.
Transl Neurodegener. 2020 May 11;9(1):17. doi: 10.1186/s40035-020-00196-0.
9
Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions.
Biomedicines. 2021 Nov 5;9(11):1625. doi: 10.3390/biomedicines9111625.
10
Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling.
Mitochondrion. 2019 Nov;49:35-45. doi: 10.1016/j.mito.2019.07.003. Epub 2019 Jul 6.
本文引用的文献
1
The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease.
Mol Neurobiol. 2020 Jul;57(7):2959-2980. doi: 10.1007/s12035-020-01926-1. Epub 2020 May 22.
2
Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease.
J Neurochem. 2018 Mar;144(6):691-709. doi: 10.1111/jnc.14308. Epub 2018 Feb 14.
3
The Autophagy-Lysosomal Pathway in Neurodegeneration: A TFEB Perspective.
Trends Neurosci. 2016 Apr;39(4):221-234. doi: 10.1016/j.tins.2016.02.002. Epub 2016 Mar 9.
4
Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies.
Prog Neurobiol. 2017 Aug;155:171-193. doi: 10.1016/j.pneurobio.2015.07.003. Epub 2015 Jul 21.
5
Mitochondrial dysfunction and oxidative stress in Parkinson's disease.
Prog Neurobiol. 2013 Jul-Aug;106-107:17-32. doi: 10.1016/j.pneurobio.2013.04.004. Epub 2013 Apr 30.
6
Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease.
Free Radic Biol Med. 2013 Sep;62:90-101. doi: 10.1016/j.freeradbiomed.2012.11.014. Epub 2012 Nov 29.
Zotero 插件